These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 27552834

  • 1. Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood.
    Bacon S, Kyithar MP, Condron EM, Vizzard N, Burke M, Byrne MM.
    Acta Diabetol; 2016 Dec; 53(6):965-972. PubMed ID: 27552834
    [Abstract] [Full Text] [Related]

  • 2. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
    Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, Ellard S, Ferrer J, Hattersley AT.
    PLoS Med; 2007 Apr; 4(4):e118. PubMed ID: 17407387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. "Please see this man with a 69-year history of hypoglycaemia".
    Gifford RM, Foteinopoulou E, Strachan MWJ.
    J R Coll Physicians Edinb; 2021 Sep; 51(3):266-268. PubMed ID: 34528616
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S.
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [Abstract] [Full Text] [Related]

  • 9. Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother.
    Vlachopapadopoulou EA, Dikaiakou E, Fotiadou A, Sifianou P, Tatsi EB, Sertedaki A, Kanaka-Gantenbein C, Michalacos S.
    J Pediatr Endocrinol Metab; 2021 Apr 27; 34(4):527-530. PubMed ID: 33031054
    [Abstract] [Full Text] [Related]

  • 10. Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia.
    McGlacken-Byrne SM, Mohammad JK, Conlon N, Gubaeva D, Siersbæk J, Schou AJ, Demirbilek H, Dastamani A, Houghton JAL, Brusgaard K, Melikyan M, Christesen H, Flanagan SE, Murphy NP, Shah P.
    Eur J Endocrinol; 2022 Feb 22; 186(4):417-427. PubMed ID: 35089870
    [Abstract] [Full Text] [Related]

  • 11. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B, Urban M, Peczyńska J, Florys B, Kowalewski M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005 Feb 22; 11(4):237-43. PubMed ID: 16232362
    [Abstract] [Full Text] [Related]

  • 12. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.
    McGlacken-Byrne SM, Hawkes CP, Flanagan SE, Ellard S, McDonnell CM, Murphy NP.
    Diabet Med; 2014 Jan 22; 31(1):e1-5. PubMed ID: 23796040
    [Abstract] [Full Text] [Related]

  • 13. Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes.
    Anuradha S, Radha V, Mohan V.
    Clin Genet; 2011 Dec 22; 80(6):541-9. PubMed ID: 21062274
    [Abstract] [Full Text] [Related]

  • 14. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
    Stanescu DE, Hughes N, Kaplan B, Stanley CA, De León DD.
    J Clin Endocrinol Metab; 2012 Oct 22; 97(10):E2026-30. PubMed ID: 22802087
    [Abstract] [Full Text] [Related]

  • 15. A rare case of congenital hyperinsulinism (CHI) due to dual genetic aetiology involving HNF4A and ABCC8.
    Apperley L, Giri D, Houghton JAL, Flanagan SE, Didi M, Senniappan S.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):301-304. PubMed ID: 30730840
    [Abstract] [Full Text] [Related]

  • 16. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH.
    Dan Med J; 2015 Sep 26; 62(9):. PubMed ID: 26324089
    [Abstract] [Full Text] [Related]

  • 17. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
    Ekholm E, Shaat N, Holst JJ.
    Acta Diabetol; 2012 Oct 26; 49(5):349-54. PubMed ID: 21761282
    [Abstract] [Full Text] [Related]

  • 18. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M, Nacarkahya G.
    J Diabetes; 2021 Feb 26; 13(2):154-163. PubMed ID: 32710514
    [Abstract] [Full Text] [Related]

  • 19. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
    Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S, Hattersley AT, Patel KA, UNITED study.
    Diabetologia; 2018 Dec 26; 61(12):2520-2527. PubMed ID: 30229274
    [Abstract] [Full Text] [Related]

  • 20. Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.
    Warncke K, Kummer S, Raile K, Grulich-Henn J, Woelfle J, Steichen E, Prinz N, Holl RW.
    J Clin Endocrinol Metab; 2019 Mar 01; 104(3):845-855. PubMed ID: 30535056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.